Vol 14 (2023): Continuous Publishing
Letter to the Editor
Published online: 2023-11-29

open access

Page views 272
Article views/downloads 89
Get Citation

Connect on Social Media

Connect on Social Media

Incidence of lymphoid malignancies in patients with lymphocytosis identified by general practitioners

Marika Kasahara1, Kajetan Karaszewski1, Maria Król1, Mateusz Ziarkiewicz1, Wiesław Wiktor Jędrzejczak1
Hematology in Clinical Practice 2023;14:52-54.


Family physicians are currently instructed to refer patients with lymphocyte counts exceeding 5 x109/L to hematologists due to the possibility of chronic lymphocytic leukemia (CLL). This study assessed the usefulness of this procedure through the analysis and evaluation of referrals made to a hematologist over a period of 12 years (2010-2022). During the 12 years, there were 256 patients whose absolute lymphocyte count at least once exceeded 5 x109/L and who were referred to our hospital. There were 145 males and 111 females in this group, and the median age was 66 y. The mean absolute lymphocyte count at the time of referral was 30.0 G/L. It was found that among the 256 patients, a diagnosis was established for 249 (97.3%) of the patients. There were 224 CLL cases, 2 SLL cases, and 5 MBL cases, making 231 cases with CLL phenotype (92.8%). There were 9 cases of other B cell lymphomas (3.6%), including 4 MCL cases, 4 MZL cases, and 1 SLVL case. Furthermore, there were 6 cases of T cell lymphomas (2.4%), including 5 T-LGL cases and 1 T-PLL case. The cohort also had 1 AML case (0.4%) and 3 reactive lymphocytosis cases (1.2%), including one with infectious mononucleosis (0.4%). In the group, 16/224 patients (7.1%) with CLL as well as one with AML required immediate treatment. The absolute lymphocyte count was confirmed as a reliable screening test for diagnosing lymphoid malignancies with peripheral blood involvement.

Article available in PDF format

View PDF Download PDF file


  1. Müller-Hermelink HK, Montserrat E, Catovsky D, Campo E, Harris NL. Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In: Swerdlow sH, Campo E, Harris NL. ed. WHO classification of tumours of the haematopoietic and lymphoid tissues. IARC Press, Lyon 2008.
  2. Jędrzejczak WW. Wczesna diagnostyka chorób krwi — wskazania do skierowania chorego do hematologa. In: Jędrzejczak WW, Robak T, Podolak-Dawidziak M M. ed. Praktyka hematologiczna. Termedia, Poznań 2017: 109–114.
  3. Hallek M, Cheson BD, Catovsky D, et al. International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008; 111(12): 5446–5456.
  4. Eichhorst B, Robak T, Montserrat E, et al. ESMO Guidelines Committee. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021; 32(1): 23–33.
  5. Hayran M, Koca E, Haznedaroglu IC, et al. Predicting chronic leukaemias from assessment of complete peripheral blood counts. J Int Med Res. 2006; 34(6): 640–647.
  6. Thalhammer-Scherrer R, Veitl M, Exner M, et al. Role of immunological lymphocyte subset typing as a screening method for lymphoid malignancies in daily routine practice. Cytometry. 2000; 42(1): 5–10.
  7. te Raa GD, Fischer K, Verweij W, et al. Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis. Clin Chem Lab Med. 2011; 49(1): 115–120.
  8. Shanafelt TD, Kay NE, Call TG, et al. MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 × 10(9) L(-1) but a B-cell lymphocyte count <5 × 10(9) L(-1)? Leuk Res. 2008; 32(9): 1458–1461.
  9. Stock W, Hoffman R. White blood cells 1: non-malignant disorders. Lancet. 2000; 355(9212): 1351–1357.
  10. Teraki Y, Shibuya M, Izaki S. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations. Clin Exp Dermatol. 2010; 35(7): 723–728.
  11. Akcam FZ, Aygun FO, Akkaya VB. DRESS like severe drug rash with eosinophilia, atypic lymphocytosis and fever secondary to ceftriaxone. J Infect. 2006; 53(2): e51–e53.
  12. Snow AL, Xiao W, Stinson JR, et al. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J Exp Med. 2012; 209(12): 2247–2261.

Hematology in Clinical Practice